To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection
Clinical trial NCT05474755 · COMPLETED
Trial details
- NCT number
- NCT05474755
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-28
- Primary completion
- 2023-04-25
- Enrollment
- 591
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.